What is your initial, ATA guidelines-sanctioned approach to therapy for hypothyroidism and when might this initial strategy require modification? How focused should we be on “squaring the numbers”—TSH and T4 and/or T3—as a benchmark for success?

What is your initial, ATA guidelines-sanctioned approach to therapy for hypothyroidism and when might this initial strategy require modification? How focused should we be on “squaring the numbers”—TSH and T4 and/or T3—as a benchmark for success?

What is your initial, ATA guidelines-sanctioned approach to therapy for hypothyroidism and when might this initial strategy require modification? How focused should we be on “squaring the numbers”—TSH and T4 and/or T3—as a benchmark for success?


Created by

CMEducation Resources IQ&A Thyroid Hormone Replacement Medical Intelligence Zone

Presenter

Christine Kessler, MN, ANP-BC, CNS, BC-ADM, FAANP

Christine Kessler, MN, ANP-BC, CNS, BC-ADM, FAANP

Founder, Nurse Practitioner Metabolic Medicine AssociatesCo-Chair, Metabolic & Endocrine Disease Summit (MEDS) King George, Virginia